These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26230317)

  • 1. Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.
    Verma M; Beaulieu-Abdelahad D; Ait-Ghezala G; Li R; Crawford F; Mullan M; Paris D
    PLoS One; 2015; 10(7):e0134776. PubMed ID: 26230317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.
    Verma M; Beaulieu-Abdelahad D; Ait-Ghezala G; Li R; Crawford F; Mullan M; Paris D
    PLoS One; 2015; 10(5):e0128224. PubMed ID: 26010758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease.
    Wang S; Cui Y; Wang C; Xie W; Ma L; Zhu J; Zhang Y; Dang R; Wang D; Wu Y; Wu Q
    PLoS One; 2015; 10(12):e0146252. PubMed ID: 26713729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.
    Paris D; Beaulieu-Abdelahad D; Bachmeier C; Reed J; Ait-Ghezala G; Bishop A; Chao J; Mathura V; Crawford F; Mullan M
    Eur J Pharmacol; 2011 Nov; 670(2-3):384-91. PubMed ID: 21958873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.
    Laurent C; Eddarkaoui S; Derisbourg M; Leboucher A; Demeyer D; Carrier S; Schneider M; Hamdane M; Müller CE; Buée L; Blum D
    Neurobiol Aging; 2014 Sep; 35(9):2079-90. PubMed ID: 24780254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.
    van Gijsel-Bonnello M; Baranger K; Benech P; Rivera S; Khrestchatisky M; de Reggi M; Gharib B
    PLoS One; 2018; 13(3):e0194586. PubMed ID: 29538465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.
    Mellott TJ; Huleatt OM; Shade BN; Pender SM; Liu YB; Slack BE; Blusztajn JK
    PLoS One; 2017; 12(3):e0174875. PubMed ID: 28334015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
    Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
    Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.
    Luo J; Lee SH; VandeVrede L; Qin Z; Ben Aissa M; Larson J; Teich AF; Arancio O; D'Souza Y; Elharram A; Koster K; Tai LM; LaDu MJ; Bennett BM; Thatcher GR
    Mol Neurodegener; 2016 Apr; 11():35. PubMed ID: 27129593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease.
    Koppel J; Jimenez H; Azose M; D'Abramo C; Acker C; Buthorn J; Greenwald BS; Lewis J; Lesser M; Liu Z; Davies P
    Behav Brain Res; 2014 Dec; 275():27-33. PubMed ID: 25151619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
    Chellappa RC; Lukose B; Rani P
    PLoS One; 2021; 16(3):e0248252. PubMed ID: 33662008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
    Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
    J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group.
    Su Y; Blazey TM; Owen CJ; Christensen JJ; Friedrichsen K; Joseph-Mathurin N; Wang Q; Hornbeck RC; Ances BM; Snyder AZ; Cash LA; Koeppe RA; Klunk WE; Galasko D; Brickman AM; McDade E; Ringman JM; Thompson PM; Saykin AJ; Ghetti B; Sperling RA; Johnson KA; Salloway SP; Schofield PR; Masters CL; Villemagne VL; Fox NC; Förster S; Chen K; Reiman EM; Xiong C; Marcus DS; Weiner MW; Morris JC; Bateman RJ; Benzinger TL;
    PLoS One; 2016; 11(9):e0163669. PubMed ID: 27649320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
    Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide treatment reduces Alzheimer's disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD.
    Wang Q; Xiao B; Cui S; Song H; Qian Y; Dong L; An H; Cui Y; Zhang W; He Y; Zhang J; Yang J; Zhang F; Hu G; Gong X; Yan Z; Zheng Y; Wang X
    Dis Model Mech; 2014 Dec; 7(12):1385-95. PubMed ID: 25481013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment with lithium alleviates memory deficits and reduces amyloid-β production in an aged Alzheimer's disease transgenic mouse model.
    Zhang X; Heng X; Li T; Li L; Yang D; Zhang X; Du Y; Doody RS; Le W
    J Alzheimers Dis; 2011; 24(4):739-49. PubMed ID: 21321394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease.
    Modi KK; Jana A; Ghosh S; Watson R; Pahan K
    PLoS One; 2017; 12(6):e0180602. PubMed ID: 28654697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Socio-behavioral risk factors among older adults living with HIV in Thailand.
    Musumari PM; Tangmunkongvorakul A; Srithanaviboonchai K; Feldman MD; Sitthi W; Rerkasem K; Techasrivichien T; Suguimoto SP; Ono-Kihara M; Kihara M
    PLoS One; 2018; 13(2):e0192818. PubMed ID: 29420615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.